Ticker
ARCTCompany Name
ARCTURUS THERAPEUTICS HOLDINGS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cash Return on Invested Capital | Free Cash Flow | Invested Capital |
---|---|---|---|
6/30/2025 | -25.65% | $ -65.16M | $ 253.99M |
3/31/2025 | -32.95% | $ -89.87M | $ 272.75M |
12/31/2024 | -22.71% | $ -60.4M | $ 265.98M |
9/30/2024 | -21.41% | $ -61.62M | $ 287.85M |
6/30/2024 | -24.92% | $ -71.16M | $ 285.55M |
3/31/2024 | 3.35% | $ 9.77M | $ 291.62M |
12/31/2023 | -6.9% | $ -21M | $ 304.42M |
9/30/2023 | 41.87% | $ 136.96M | $ 327.08M |
6/30/2023 | 40.14% | $ 125.75M | $ 313.29M |
3/31/2023 | 10.84% | $ 38.85M | $ 358.44M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Inv. Capital
(=) CROIC
CROIC for ARCTURUS THERAPEUTICS HOLDINGS INC is calculated as follows: FCF [ $ -45.13M ] / Inv. Capital [ $ 280.86M ]
(=) CROIC [ -16.07% ]
Minimum
Sep 30, 2022
Maximum
Sep 30, 2023
Average
Median
filtered constituents | 3.46K |
---|---|
min | -43.78% |
max | 49.3% |
average | 2.78% |
median | 4.97% |
std | 15.05% |